- Assistant Professor, Physics Department, Princeton University, 1993-2001
- Member, The Institute for Advanced Study, 1991-1993
- Research Physicist, Institute for Theoretical Physics, University of California, 1988-1991
- Ph.D., Princeton University, 1988
- M.A., Princeton University, 1984
- B.S., California Institute of Technology, 1983
The ultimate goal of our research is to predict quantitatively the effects of therapeutic interventions in human disease.
Data-driven large-scale biological modeling of disease
Biology is complex. For example, diabetes is the end result of a long process of increasing insulin resistance culminating in an inability to produce sufficient insulin to keep glucose levels under control. This increasing insulin resistance is the result of several interacting processes that are still being sorted out, such as increasing fat mass and increasing mitochondrial dysfunction. At the cellular level, at the organ level and at the whole body level, predictive models of this dysfunction are important to integrate different scales in space and time into a coherent whole. New technologies provide increasingly detailed data on underlying biological signaling networks. Extracting predictive models of disease causes from such large-scale data directly is a difficult but essential problem in modern biology. The goal of our research is to deduce data-driven unbiased mathematical models that can be used to help find interventions that can guide therapy for complex diseases.
Model of Reactive Oxygen Species in Mitochondria
Reactive oxygen species (ROS) have been shown to have tissue-damaging effects that underlie many disease complications, including those associated with diabetes, Parkinson's, Alzheimer's, and atherosclerosis (Brownlee, 2005). This oxidative stress is thought to result from an organism's inability to detoxify and repair damage at the same rate that ROS are produced. On the other hand, it should be noted that ROS signaling is important in cellular functioning. In mitochondria, where ROS (e.g., superoxide) are produced through a process that is very sensitive to the proton motive force, oxidative stress is prevented by scavenging enzymes (e.g., MnSOD) and uncoupling proteins (e.g., UCP2). Details of this regulation in mitochondria are still being established. The interplay between nutrient sensing and ROS signaling is complex, and the goal of our research is to mathematically model the relevant pathways to understand the deleterious aspects of this interplay as it relates to the metabolic syndrome and obesity.
Adipocyte Development and Insulin Resistance
Our overall goal is to understand how adipose tissue dynamics are related to insulin resistance and diabetes. Adipose tissue grows by two mechanisms: hyperplasia (cell number increase) and hypertrophy (cell size increase). How do genetics and diet affect the relative contributions of these two mechanisms to the growth of adipose tissue in obesity? We are particularly interested in investigating the role played by insulin-sensitizing agents such as thiazoledinediones in altering the development of adipocytes. We chose to investigate this dynamic behavior by mathematically modeling the changes in cell size distributions in adipose tissue over time under several conditions, since this will provide a global view of cell size dynamics as adipocytes accumulate lipids and move from small sizes to maturity.
- Data-driven inference of hidden nodes in networks.
- Hoang DT, Jo J, Periwal V.
- Phys Rev E (2019 Apr) 99:042114. Abstract/Full Text
- A mathematical model of calcium dynamics: Obesity and mitochondria-associated ER membranes.
- Han JM, Periwal V.
- PLoS Comput Biol (2019 Aug) 15:e1006661. Abstract/Full Text
Research in Plain Language
Insulin resistance is a major risk factor for several common diseases. These include diabetes, heart disease, high blood pressure, and some forms of cancer. Scientists do not yet understand how cells become insulin resistant. Our research group studies three processes related to insulin resistance.
We study problems in insulin’s ability to control the breakdown of fat. This leads to increased levels of free fatty acids (FFA) in the blood. With elevated FFA levels, insulin does not work as well as it should in tissues or cells. A way to measure insulin’s effects on fat break down and blood FFA levels would help monitor various conditions of insulin resistance. We are developing an index to show how FFA levels respond to insulin. Many disease complications relate to oxidative stress. These include problems associated with diabetes, Parkinson's, Alzheimer's, and hardening of the arteries. In oxidative stress, the body cannot remove toxins and repair damage caused by reactive oxygen species (ROS). But ROS are not always bad. ROS signaling is important in how cells work. Cellular structures that produce energy, mitochondria, have ROS but do not show oxidative stress. Using math, we develop models to describe how this happens. The goal is to understand the damage of oxidative stress in insulin resistance and obesity.
Our research also aims to understand how fat tissue growth relates to insulin resistance and diabetes. Fat tissue grows in two ways—when the number of cells increase and when the size of cells increase. How do genetics and diet affect the number and size of fat cells in obesity? We focus on the role played by particular agents that increase insulin sensitivity. Using math, we model changes in fat cell size over time under several conditions. This work will provide a global view of fat cell size and fat tissue growth in conditions featuring insulin resistance.